Optical Goods Retailers (U.S.) — NAICS 45613

A short rollup primer on the stores that sell eyeglasses, contact lenses, and sunglasses to American consumers — for both public-market and private investors. This level equals its single child industry, 456130; see that primer for full detail.

1. Overview

NAICS 45613 (the North American Industry Classification System, the U.S. government's standard scheme for grouping businesses) is the industry that captures where Americans actually buy vision correction: prescription eyeglasses, contact lenses, and prescription and non-prescription sunglasses. It spans the LensCrafters at the mall, the America's Best in a strip center, the independent optician on Main Street, and online sellers like Warby Parker and Zenni.

The category is a hybrid of health care and consumer retail. Customers need correction, but retailers still compete on price, fashion, convenience, insurance acceptance, speed, and trust — giving the business staple-like, recurring characteristics (scheduled contact-lens refills, style-driven frame replacement, annual exams) that most discretionary retail lacks. At the same time it is being reshaped by direct-to-consumer (DTC — selling straight to shoppers online and through owned stores) upstarts, private-equity roll-ups, and a new smart-glasses category.[1]

2. What's inside — and why this level equals its one child

In the 2022 NAICS structure, the five-digit industry 45613 contains exactly one six-digit national industry: 456130, Optical Goods Retailers. There is no second sibling to aggregate, so the five-digit rollup is, for every practical purpose, identical to the six-digit leaf — same scope, same firms, same receipts, same concentration. The two codes differ only in taxonomy depth, not in economic content.

Scope. The industry covers stores that (1) retail and fit prescription eyeglasses and contact lenses, (2) retail eyeglasses while grinding lenses to order on site, or (3) retail non-prescription eyeglasses and sunglasses.[2] It is a store category and deliberately excludes big adjacent pieces of eyewear economics: optometrists' and ophthalmologists' offices (health care, NAICS 621), stand-alone lens manufacturing (NAICS 339115), and optical counters inside general-merchandise giants such as Walmart, Costco, and Sam's Club (folded into their parent stores).[2] Because those exclusions matter for every official number, this rollup carries the same undercount caveat as its child.

Because everything below is inherited from the single child, this page stays short. For the full treatment — ownership structure, the investable universe, unit economics, demand drivers, regulation, consolidation, risks, and how-to-invest detail — read the 456130 primer.

3. Size (this level's rollup figures)

The figures below are our ingested federal ground truth for NAICS 45613. Because the level has one child, they equal the 456130 figures.

The Herfindahl-Hirschman Index (HHI, a standard measure that squares and sums every firm's market share) is suppressed in the federal data for this industry, so we do not report a value. Our ingested stats for this five-digit level do not include establishment, employment, or payroll counts; the child primer carries those from County Business Patterns (about 11,719 store locations and 79,762 paid employees in 2023).[4]

Undercount caveat (read before quoting any number). The $15.68 billion is the receipts of firms classified specifically as optical goods stores.[3] It is a floor, not the whole eyewear economy. It excludes the self-employed and no-employee businesses, and it omits exam and product revenue at optometrists' offices, online pure-plays, and Walmart/Costco optical departments — so much of the industry's real economic footprint, especially where small or individual ownership dominates, falls outside the count. Trade estimates of the broader U.S. optical market run far higher (The Vision Council put it near $69.5 billion for 2025), but those figures count eye exams and categories outside this store code and are not comparable with the $15.68 billion.[1]

4. Investable universe (where value concentrates)

Because the level is its one child, value concentrates exactly as it does in 456130. Few clean public plays exist; most large chains are private or owned by insurers and private-equity firms. Tickers and prices are reserved for this section.

• Public: the global giant EssilorLuxottica (EL / ESLOY) — lens maker, brand owner (Ray-Ban, Oakley), and retailer (LensCrafters, Sunglass Hut, Pearle Vision, Target Optical) plus the EyeMed insurance network; the value chain National Vision Holdings (EYE); and the DTC brand Warby Parker (WRBY).[1]
• Private / other owners: VSP Vision (member-owned insurer that owns Visionworks and Eyemart Express), Goldman-backed MyEyeDr, Partners Group's EyeCare Partners, founder-owned Now Optics / Stanton Optical, the Vision Source buying alliance of independents, Zenni, and KKR-owned 1-800 Contacts.[1]

Walmart and Costco rank near the top of U.S. optical-sales tables but embed optical in their health/ancillary operations with no standalone disclosure, so they are not meaningful eyewear investments. No single listed company cleanly represents the whole category. See the 456130 primer for the full company-by-company breakdown.

5. How the money works

Same economics as the child. Retailers run on two engines — product (frames, prescription lenses, contact lenses, sunglasses) and services (eye exams and fittings, usually via an affiliated optometrist) — layered with memberships, subscriptions, and managed-care contracts. Frames and lenses carry famously high retail markups, but rent, licensed labor, marketing, and lab costs consume much of the gross margin, leaving ordinary retail operating margins; contact lenses add recurring demand at lower margins.[1] Owners and investors watch comparable-store ("same-store") sales, average ticket and add-on attach rate, exam capacity and exam-to-purchase conversion, managed-care versus self-pay mix, and — for DTC brands — active customers and retention. Three models coexist: value (America's Best), premium (LensCrafters), and DTC (Warby Parker).[1]

6. Demand drivers

Unchanged from the child: an aging population (near-universal presbyopia, age-related loss of near focus, from the mid-40s) is the dominant tailwind; penetration is high and sticky (about 94% of U.S. adults use some eyewear; roughly 45 million wear contact lenses); rising myopia (nearsightedness, linked to screen time) pulls demand to younger ages; frames double as fashion with short replacement cycles; and smart glasses (Ray-Ban Meta, forthcoming Google/Warby devices) add a potential technology-upgrade cycle. Glasses remain a somewhat deferrable big-ticket buy, so demand softens in downturns while exams and contact refills behave more like staples.[1]

7. Regulation

Same regime as 456130. The retail sale sits atop federal pro-competition rules — the FTC Eyeglass Rule and Contact Lens Rule (the Federal Trade Commission requires prescribers to hand over prescriptions so shoppers can fill them anywhere) — plus FDA oversight of contact lenses as medical devices and impact-resistant spectacle lenses, and state licensing / corporate-practice laws that typically separate the retail company from a physician-owned professional entity through a management-services organization (MSO).[1]

8. Consolidation

Also inherited whole. Two vertically integrated giants — EssilorLuxottica across manufacturing, brands, retail, and insurance, and VSP Vision on the payer side (largest vision insurer, also a retailer) — shape both what insurance covers and where consumers buy. The federal data show the concentration directly: the top four firms hold 61.5% of receipts and the top 50 hold 80.5%,[3] yet the market stays locally fragmented because independents, franchises, and licensed departments sit alongside the chains. Private-equity and strategic roll-ups (MyEyeDr, EyeCare Partners, Eyemart Express, 1-800 Contacts) continue to consolidate the space.[1]

9. Risks

The same risks apply as at the child level: consumer/macro sensitivity on deferrable purchases; payer pressure from two dominant vision-benefit networks; a shortage of licensed optometrists that constrains exam-lane capacity and store growth; tariffs on China-made frames (2025 increases pushed some combined duties well over 100%); price and online competition; regulatory change to the FTC prescription-release rules; antitrust scrutiny of the integrated giants; roll-up/debt risk in private-equity platforms; and long-run substitution from refractive surgery and myopia-control treatments. A measurement risk sits on top: federal statistics omit or misclassify much optical activity, making market-size comparisons unreliable.[1]

10. How to invest, and outlook

Because this rollup equals its one child, the routes are identical. Public investors reach the sector through EssilorLuxottica (the diversified way to own the whole value chain), National Vision (the clearest U.S. optical pure-play), and Warby Parker (the DTC growth story with smart-glasses optionality); contact-lens makers (Alcon, Cooper, Bausch + Lomb) offer adjacent supplier exposure. Private investors buy or franchise a store, back a retail or practice-management platform, finance labs and technology, or co-invest with the private-equity firms and insurers rolling up practices — with due diligence on same-store sales, average ticket, insurer mix, exam conversion, labor availability, new-store payback, and state corporate-practice compliance.

Outlook. The demographic base is durable and slow-moving in the industry's favor — aging, rising myopia, and heavy screen use all point to steady long-run demand, and the physical store is not going away. Value and DTC formats look positioned to keep taking share from full-price premium chains, consolidation of independents should continue, and the genuine wild card is the smart-glasses land grab. Those are judgments about the future, not settled facts. For the complete analysis, see the 456130 primer.

---

Sources

1. Optical Goods Retailers primer, NAICS 456130 (this project's child-industry primer), which synthesizes and cites SEC filings (EssilorLuxottica, National Vision, Warby Parker), The Vision Council Market inSights 2025, Vision Monday's Top 50 U.S. Optical Retailers, the U.S. National Eye Institute, the CDC, the FTC Eyeglass and Contact Lens Rules, the FDA, and trade and news reporting on tariffs, smart glasses, and private-equity consolidation. See that primer's Sources list for the full underlying citations.
2. U.S. Census Bureau, 2022 NAICS: 456130 Optical Goods Retailers (definition and cross-references to 621320 and 339115). https://www.census.gov/naics/?details=456130&input=456130&year=2022
3. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms, NAICS 45613 (firms, receipts, CR4/CR8/CR20/CR50; HHI suppressed). https://api.census.gov/data/2022/ecnsize/groups/EC2200SIZECONCEN.html
4. U.S. Census Bureau, County Business Patterns, NAICS 456130, 2023 (establishments and employment, carried from the child primer). https://data.census.gov/table/CBP2023.CB2300CBP